Medicare Enrolled
Dr. Kristin Fless, M.D.
Pulmonary Disease · Livingston, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fless from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fless?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fless
Dr. Kristin Fless is a pulmonary disease specialist in Livingston, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Fless performed 708 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Fless received a total of $6,946 from 58 pharmaceutical and/or device companies across 291 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fless is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ 708 Medicare services
$6,946 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗708
Medicare services
Bottom 28% in NJ for pulmonary disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
214 | $106 | $841 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
113 | $65 | $345 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
63 | $99 | $477 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
45 | $8 | $56 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
45 | $73 | $603 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
34 | $10 | $76 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
33 | $105 | $622 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
29 | $9 | $81 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
26 | $39 | $163 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
19 | $7 | $53 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
16 | $72 | $420 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
16 | $149 | $874 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
16 | $34 | $156 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
14 | $54 | $1,481 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $141 | $1,106 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
12 | $35 | $260 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$6,946
Total received (2018-2024)
Avg $992/year across 7 years
Top 20% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
291
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$625
2023
$271
2022
$686
2021
$1,996
2020
$747
2019
$1,900
2018
$720
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$169
GlaxoSmithKline, LLC.
$136
Regeneron Healthcare Solutions, Inc.
$97
Avadel CNS Pharmaceuticals, LLC
$54
Harmony Biosciences Llc
$31
Inari Medical, Inc.
$23
PFIZER INC.
$18
Mylan Specialty L.P.
$17
ABBVIE INC.
$17
HARMONY BIOSCIENCES LLC
$16
Amgen Inc.
$16
Gilead Sciences, Inc.
$15
Chiesi USA, Inc.
$14
Top 3 companies account for 64.5% of 2024 payments
All-time payments by company (2018-2024) ›
Ethicon Inc.
$1,735
GlaxoSmithKline, LLC.
$942
AstraZeneca Pharmaceuticals LP
$625
Covidien LP
$444
Boehringer Ingelheim Pharmaceuticals, Inc.
$389
Advanced Respiratory, Inc
$232
Pulmonx Corporation
$230
Allergan Inc.
$197
Regeneron Healthcare Solutions, Inc.
$152
Gilead Sciences, Inc.
$133
Merck Sharp & Dohme Corporation
$112
Mylan Specialty L.P.
$111
GENZYME CORPORATION
$106
Alexion Pharmaceuticals, Inc.
$105
Grifols USA, LLC
$94
Jazz Pharmaceuticals Inc.
$94
Actelion Pharmaceuticals US, Inc.
$84
JAZZ PHARMACEUTICALS INC.
$74
Philips Electronics North America Corporation
$64
Bayer HealthCare Pharmaceuticals Inc.
$63
CSL Behring
$55
ABBVIE INC.
$55
Avadel CNS Pharmaceuticals, LLC
$54
UCB, Inc.
$44
Edwards Lifesciences Corporation
$43
AbbVie Inc.
$42
Merck Sharp & Dohme LLC
$41
Circassia Pharmaceuticals Inc
$41
Allergan, Inc.
$38
ADVANCED RESPIRATORY, INC
$34
Harmony Biosciences Llc
$31
PORTOLA PHARMACEUTICALS, LLC
$30
Amgen Inc.
$29
Chiesi USA, Inc.
$27
Mallinckrodt Hospital Products Inc.
$27
Medtronic, Inc.
$26
Inari Medical, Inc.
$23
Mallinckrodt LLC
$22
PORTOLA PHARMACEUTICALS, INC.
$21
Shire North American Group Inc
$20
PFIZER INC.
$18
La Jolla Pharmaceutical Company
$17
Bayer Healthcare Pharmaceuticals Inc.
$16
HARMONY BIOSCIENCES LLC
$16
Insmed, Inc.
$15
Baxter Healthcare
$15
Genentech USA, Inc.
$15
AbbVie, Inc.
$15
Bioventus LLC
$15
Harmony Biosciences LLC
$14
Mallinckrodt Enterprises LLC
$13
Shionogi Inc
$13
Takeda Pharmaceuticals U.S.A., Inc.
$13
Boston Scientific Corporation
$12
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$12
Nabriva Therapeutics, plc
$12
Sanofi Pasteur Inc.
$11
Itamar Medical Inc
$11
Top 3 companies account for 47.5% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · Arikayce · BEVYXXA · BREO · BREZTRI · BREZTRI AEROSPHERE · Briviact · CABLIVI · CHARTIS CATHETER · CLEVIPREX · Creon · DIFICID · DUPIXENT · EXALT · Esbriet · Exogen · FASENRA · FLOWTRIEVER CATHETER · FLUZONE HIGH-DOSE · Fetroja · GIAPREZA · GLASSIA · Hillrom - Volara System · KENGREAL · Kcentra · LUMRYZ · Life 2000 Ventilation System · MONARCH · Monarch · Monarch Platform · NIOX VERO · NUCALA · OFEV · OFIRMEV · OPSUMIT MACITENTAN · PREVNAR 20 · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · S · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · The Vest System Model 105 Home Care · ULTOMIRIS · UPTRAVI · WAKIX · WatchPATONE · XIFAXAN · XYREM · Xenleta · Xyrem · YUPELRI · Yupelri · ZERBAXA · superDimension
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
535
County median income
$76,712
Nearest hospital to ZIP centroid (approximate)
COOPERMAN BARNABAS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fless is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fless experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Fless performed 214 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Fless receive payments from pharmaceutical companies?
Yes. Dr. Fless received a total of $6,946 from 58 companies across 291 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fless's costs compare to other pulmonary diseases in Livingston?
Dr. Fless's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fless) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Livingston
Browse pulmonary diseases in Livingston ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NJ
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NJ
Which NJ pulmonary diseases receive the most from drug and device companies.
By company
Ethicon Inc. Payments to Doctors
See all physicians who received payments from Ethicon Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology